News

Bank of America Boosts IBM Price Target Before Earnings Call

Bank of America Boosts IBM Price Target Before Earnings Call

Bank of America Raises Price Target for IBM Shares

Bank of America recently announced an increase in its price target for IBM shares to $260 from the previous $250, while maintaining a Buy rating for the company. This change in outlook arrives just ahead of IBM’s much-anticipated earnings report and Investor Day, creating significant interest amongst investors.

Upcoming Earnings and Strategic Updates

IBM is set to release its Q4 earnings results soon, and during the Investor Day, the company plans to share updates regarding its mid-term targets. Insights from these events are crucial for stakeholders aiming to gauge the company's future pathways.

Q4 Earnings Expectations

The BofA team has provided projections for IBM's Q4 results, suggesting revenues of $17.5 billion and earnings per share (EPS) of $3.71. These estimates slightly miss Wall Street's predictions, which anticipate revenue of $17.6 billion and EPS of $3.80.

First Quarter Projections for FY 2025

For the first quarter of the fiscal year 2025, Bank of America's revenue forecast aligns closely with consensus at $14.6 billion. However, they project a higher EPS of $1.66, contrasting with analysts' expectations of $1.57.

Long-term Growth Expectations

Looking further down the line, BofA envisions a robust growth trajectory for IBM. They anticipate a full-year 2025 revenue increase of approximately 7% in constant currency, surpassing the overall market expectation of a 4.5% growth. This positive outlook reflects the company's strategies and market positioning.

Free Cash Flow and Foreign Exchange Considerations

Additionally, IBM's projected free cash flow (excluding financing receivables) is expected to range between $12.5 billion and $13 billion. This is slightly higher than the consensus estimate of $12.6 billion but accounts for foreign exchange headwinds estimated to impact results by 150 to 200 basis points.

Mid-term Revenue Growth Rates

During the upcoming Investor Day, industry analysts expect IBM to provide updates about its mid-term revenue growth targets. BofA forecasts a compound annual growth rate (CAGR) for revenue of 6-8% from 2024 to 2027. Notably, the Software segment is anticipated to see high single-digit percentage CAGR, reflecting growing investments and market demand.

Performance Across Business Segments

In the Consulting segment, Bank of America estimates moderate growth in the mid-single-digit percentage range, while the Infrastructure sector is projected to achieve a more modest CAGR of around 1%. Analysts predict a resurgence in the Consulting segment during the latter half of 2025 after a weaker start to the year. Meanwhile, they expect the Infrastructure segment to experience approximately 6% growth, driven significantly by the introduction of the new Z17 mainframe cycle slated to begin mid-year.

Monitoring Software Segment Developments

IBM’s Software segment remains a focal point, especially with the performance of Red Hat under close scrutiny. Additionally, there is keen interest in how recent acquisitions, such as HashiCorp and Neural Magic, will influence IBM’s AI strategy. As analysts have noted, if the HashiCorp transaction goes through, preliminary insights into potential synergies and integration within the Software segment will likely be shared.

Future Synergies and Company Strategy

Wamsi Mohan, leading the analysis team at BofA, emphasized that the forthcoming discussions about HashiCorp's integration into IBM's strategy could provide valuable information regarding the company's overarching goals in the software domain.

Frequently Asked Questions

What is the new price target for IBM shares set by Bank of America?

The new price target for IBM shares set by Bank of America is $260.

When is IBM expected to announce its Q4 earnings?

IBM is expected to announce its Q4 earnings report shortly, with specific dates to be confirmed.

What growth rate is BofA projecting for IBM from 2024 to 2027?

BofA is projecting a compound annual growth rate (CAGR) of 6-8% for IBM from 2024 to 2027.

How are IBM's Software and Consulting segments performing?

The Software segment is expected to show high single-digit growth, while the Consulting segment is predicted to grow in the mid-single digits.

What impact might the HashiCorp acquisition have on IBM?

The HashiCorp acquisition could lead to new synergies and alignments within IBM's Software segment, enhancing its AI strategy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Humble Bundle Raises Funds for Kidney Foundation

Updated Category News Views 126

Humble Bundle Lends a Hand to Kidney Health There's something heartening in the way gaming and charity collide, especially when it comes down in favor of public health. Humble Bundle's latest charitable endeavor, the "Phunkier Physics" bundle, ropes in funds to battle kidney disease, a villain in its own right that affects millions. The initiative runs till November 13,...

Continue Reading
MadaLuxe Snags DUXIANA in North American Expansion

Updated Category News Views 76

MadaLuxe's Bold Step into Luxury Sleep Here's a twist in the luxury game: MadaLuxe Group has grabbed the reins of DUXIANA's North American distribution business. If you haven't run into this iconic Swedish brand yet, it's been peddling high-end beds for a good century. Yep, 100 years of Swedish craftsmanship now in the pocket of MadaLuxe. They didn't spill any beans on...

Continue Reading
Prison Film 'Basement People' Reaches Nationwide Audience

Updated Category News Views 76

Prison Creativity Finds a Wider Stage Out from behind bars, some stories still have a long way to travel—but make no mistake, when they do, they pack a punch. “Basement People,” a short film penned by incarcerated writer Kyale Akeem Williams, is making its rounds and stirring up attention as if its origins were pure Hollywood. This film has taken a noteworthy path...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 74

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Updated Category News Views 57

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Continue Reading
MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

Updated Category News Views 51

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 39

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 0

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 9

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
FirstService Unveils New LA Luxury Living Insights

Updated Category News Views 179

Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....

Continue Reading

Top 5 Most Recently Viewed Articles

SL Green Realty's Q4 Success Boosts Market Confidence

Updated Category News Views 97

SL Green Realty's Impressive Q4 Performance SL Green Realty (NYSE: SLG), a leading office real estate investment trust based in New York, has captured the market's attention with a remarkable surge in its share price, rising as much as 4.2% in premarket trading recently. This uptick follows the company's robust fourth quarter results, which exceeded analysts'...

Continue Reading
Discover Chippewa Boots' Newest October Selection for Workers

Updated Category News Views 182

October Boot of the Month: The Paladin and Tinsley Chippewa Boots proudly presents its October Boot of the Month: the Paladin and Tinsley, both exceptional 8-inch Waterproof Insulated Steel Toe Loggers. These boots are designed to excel in tough work environments while providing the necessary protection, comfort, and performance that professionals need. Features of the...

Continue Reading
Omada Partners with GRO and Kirk Kapital for Growth in IGA

Updated Category News Views 431

Omada Secures Investment to Enhance Identity Governance Solutions Omada A/S is excited to announce a transformative phase in its journey with the backing of existing investor GRO and new partner Kirk Kapital. This investment is set to enhance Omada's position as a leading provider of Identity Governance and Administration (IGA) software, enabling significant expansion and...

Continue Reading
Royalty Pharma Strengthens Portfolio with $125 Million Acquisition

Updated Category News Views 134

Royalty Pharma Expands Its Royalty Portfolio Royalty Pharma plc (Nasdaq: RPRX) is set to enhance its standing in the biopharmaceutical industry by acquiring a synthetic royalty related to Geron Corporation’s RYTELO (imetelstat) for an upfront payment of $125 million. This acquisition underscores Royalty Pharma's commitment to advancing biopharmaceutical innovation and...

Continue Reading
Rocket Lab Prepares for Upcoming Quarterly Financial Update

Updated Category News Views 158

Rocket Lab’s Anticipation for Third Quarter Results Announcement Rocket Lab Corporation (NASDAQ: RKLB), a prominent player in the launch services and space systems arena, has officially announced its plans for revealing third quarter financial results for the year 2025. This eagerly awaited event is set to take place following the closure of U.S. markets on a scheduled...

Continue Reading